Loading...

PRTA PROTHENA CORP PUBLIC LTD CO Financial Troubles 8-K Filing

PRTH

PRT

PROTHENA CORP PUBLIC LTD CO

(PRTA)

2025 8-K

Director Resignation

Capital Reduction Approved

Financial Results Released

Drug Update Announcement

Product Expansion

Financial Statements

Management Changes

Product Expansion

Product Discontinuation

Financial Statements

Financial Results

Director Resignation

Q3 Financial Results

Management Change

Financial Results Announcement

Annual Meeting Approval

Earnings Reports

Appointment of Director

Earnings Release

Financial Update

Earnings Release

Earnings Release

Annual Meeting Approval

Appointment of Director

Earnings Release

Resignation of Director

Regulation FD Disclosure

Earnings Report

External Links:

On August 6, 2025, Prothena Corporation announced that its partner, Novo Nordisk, will advance the drug coramitug into Phase 3 development for treating ATTR amyloidosis with cardiomyopathy. This is a significant development for the company.

AI Assistant

PROTHENA CORP PUBLIC LTD CO

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.